Cargando…
Delayed reversal of methanol-induced blindness in an adult by a combination of erythropoietin and a high dose of methylprednisolone: a case report
BACKGROUND: The clinical manifestation following methanol toxicity accounts for a life-threatening problem that contributes to metabolic disorders, neurological complications, blindness, and even death. There is no completely effective treatment to retain the patient’s vision. Herein, we apply a new...
Autores principales: | Vafapour, Fatemeh, Jahangiri-Mehr, Sajad, Hassanzadeh, Sajad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116800/ https://www.ncbi.nlm.nih.gov/pubmed/37076901 http://dx.doi.org/10.1186/s13256-023-03899-w |
Ejemplares similares
-
Outbreak of methanol-induced optic neuropathy in early COVID-19 era; effectiveness of erythropoietin and methylprednisolone therapy
por: Tabatabaei, Seyed Ali, et al.
Publicado: (2023) -
Visual Outcomes of Adding Erythropoietin to Methylprednisolone for Treatment of Retrobulbar Optic Neuritis
por: Sanjari, Mostafa Soltan, et al.
Publicado: (2019) -
Effects of erythropoietin and methylprednisolone on AQP4 expression in astrocytes
por: Wang, Changchao, et al.
Publicado: (2017) -
Related Fluoxetine and Methylprednisolone Changes of TNF-α and IL-6
Expression in The Hypothyroidism Rat Model of Spinal Cord Injury
por: Zirak, Atousa, et al.
Publicado: (2021) -
Recombinant human erythropoietin plus methylprednisolone versus methylprednisolone in treatment of acute spinal cord injury:protocol for a systematic review and meta-analysis
por: Fang, Miao, et al.
Publicado: (2022)